Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neurogene (NGNE) Interest Expenses (2019 - 2025)

Neurogene (NGNE) has disclosed Interest Expenses for 4 consecutive years, with -$77000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Interest Expenses fell 2666.67% year-over-year to -$77000.0, compared with a TTM value of $6000.0 through Sep 2025, down 99.47%, and an annual FY2024 reading of $12000.0, down 57.14% over the prior year.
  • Interest Expenses was -$77000.0 for Q3 2025 at Neurogene, down from $1000.0 in the prior quarter.
  • Across five years, Interest Expenses topped out at $602000.0 in Q1 2024 and bottomed at -$77000.0 in Q3 2025.